TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.30
-0.10 (-0.20%)
May 12, 2025, 1:30 PM CST

TSH Biopharm Corporation Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
102.58113.0961.9961.8947.1161.57
Upgrade
Depreciation & Amortization
28.2627.5621.3420.619.659.54
Upgrade
Other Amortization
1.41.41.230.910.140.11
Upgrade
Loss (Gain) From Sale of Assets
0.870.870.040.060-
Upgrade
Asset Writedown & Restructuring Costs
8.88.8--4.154.58
Upgrade
Loss (Gain) From Sale of Investments
-1.11----1.56
Upgrade
Provision & Write-off of Bad Debts
0.790.76-1.933.04-0.1-0.1
Upgrade
Other Operating Activities
44.3535.14-8.83-1.3-15.640.95
Upgrade
Change in Accounts Receivable
-24.9648.61-5.52-10.419.055.14
Upgrade
Change in Inventory
-42.61-44.91-11.01-13.954.69-18.85
Upgrade
Change in Accounts Payable
0.41-43.14-5.93-49.466.33-34.66
Upgrade
Change in Unearned Revenue
0.97-0.8-3.595.23--2.48
Upgrade
Change in Other Net Operating Assets
37.3636.4-13.9317.743.34-15.74
Upgrade
Operating Cash Flow
157.09183.7733.8734.3568.7111.61
Upgrade
Operating Cash Flow Growth
77.56%442.54%-1.40%-50.00%491.74%-86.90%
Upgrade
Capital Expenditures
-2.96-1.73-5.38-3.73-0.38-1.92
Upgrade
Sale of Property, Plant & Equipment
0.30.3-0.03--
Upgrade
Cash Acquisitions
-242.87-242.87----
Upgrade
Sale (Purchase) of Intangibles
-5.52-1.02-0.18-15--0.46
Upgrade
Investment in Securities
113.63127.94167.8744.67-14.28229.43
Upgrade
Other Investing Activities
7.156.99-1.297.424.67.16
Upgrade
Investing Cash Flow
-128.81-110.38161.0233.4-10.06234.21
Upgrade
Short-Term Debt Issued
---20--
Upgrade
Long-Term Debt Issued
---30--
Upgrade
Total Debt Issued
---50--
Upgrade
Short-Term Debt Repaid
---20-61.07--
Upgrade
Long-Term Debt Repaid
--12.54-35.73-20.93-4.35-4.22
Upgrade
Total Debt Repaid
-13.68-12.54-55.73-82-4.35-4.22
Upgrade
Net Debt Issued (Repaid)
-13.68-12.54-55.73-32-4.35-4.22
Upgrade
Common Dividends Paid
-49.15-49.15-61.44-57.6-69.12-69.12
Upgrade
Other Financing Activities
--9.990.2--
Upgrade
Financing Cash Flow
-62.83-61.69-107.18-89.4-73.46-73.33
Upgrade
Foreign Exchange Rate Adjustments
0.030.06-0.030.03--
Upgrade
Net Cash Flow
-34.5211.7687.68-21.62-14.81172.49
Upgrade
Free Cash Flow
154.13182.0428.4930.6268.339.7
Upgrade
Free Cash Flow Growth
76.80%538.93%-6.96%-55.18%604.75%-88.68%
Upgrade
Free Cash Flow Margin
12.82%16.32%3.51%4.13%16.52%2.17%
Upgrade
Free Cash Flow Per Share
4.014.740.740.801.780.25
Upgrade
Cash Interest Paid
0.460.460.690.70.080.03
Upgrade
Cash Income Tax Paid
19.2419.2415.913.9823.748.29
Upgrade
Levered Free Cash Flow
-224.33138.948.75-18.8562.7-1.52
Upgrade
Unlevered Free Cash Flow
-223.94139.239.18-18.4162.75-1.5
Upgrade
Change in Net Working Capital
350.42-6.8647.662.47-18.5955.21
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.